A recent UK nested case-control study and meta-analysis examined the association between combined and progestagen-only hormonal contraceptives and breast cancer risk. The study, which was published on March 21, 2023, found that there is a small but significant increased risk of breast cancer associated with the use of hormonal contraceptives. The researchers found that women […]
Hormonal Contraceptives And Breast Cancer Risk Read More »
Antimicrobial resistance is largely driven by the overuse and misuse of antibiotics. However, the impact of other drugs in this process is often overlooked. Recently, Australian scientists conducted a study published in the journal PNAS showing that certain antidepressants, such as sertraline and duloxetine, can induce resistance in E. coli to various antibiotics. This highlights
Antidepressants as a New Player in Antibiotic Resistance? Read More »
Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant) nasal spray for the acute treatment of migraine with or without aura in adults. This is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray. ZAVZPRET has been proven effective, tolerable, and safe in two
Pfizer’s ZAVZPRET™ nasal migraine spray is the first to be approved by the FDA Read More »